Metronidazole (Flagyl / Metroplex)

Metronidazole stands as one of the most important and widely used medications in the aquarium hobby for treating internal protozoan parasites and anaerobic bacterial infections in ornamental fish. Originally developed for human medicine under the brand name Flagyl, this nitroimidazole antibiotic has proven remarkably effective against a range of fish pathogens that cause devastating diseases in freshwater aquariums. The medication works by disrupting the DNA synthesis of susceptible organisms, making it particularly lethal against anaerobic bacteria and certain protozoan parasites that thrive in low-oxygen environments within the fish's digestive system and internal organs.

The mechanism of action for metronidazole involves the drug entering susceptible cells where it undergoes reduction by intracellular electron transport proteins. This reduction process creates reactive intermediates that damage the DNA of the target organisms, preventing replication and ultimately causing cell death. This selective toxicity makes metronidazole highly effective against anaerobic organisms while having relatively minimal impact on the beneficial aerobic bacteria that power the nitrogen cycle in aquarium filtration systems. The drug's ability to penetrate tissues effectively allows it to reach parasites and bacteria residing deep within the fish's gastrointestinal tract and other internal organs where many medications cannot reach.

Metronidazole is available in several forms for aquarium use, including pure pharmaceutical-grade powder, commercial aquarium preparations like Seachem Metroplex, and combination products such as API General Cure that pair metronidazole with other antiparasitic compounds. The pure powder form offers the most flexibility in dosing but requires precise measurement and often a prescription. Commercial aquarium preparations have made this essential medication accessible to hobbyists without veterinary involvement, though the concentrations may vary between products. Some preparations are designed specifically for mixing with food, while others dissolve readily in water for tank treatment.

The overall safety profile of metronidazole in aquarium applications is considered favorable when used according to proper protocols. The medication has been used successfully across a wide range of freshwater fish species with minimal adverse effects when dosed correctly. However, its effectiveness depends heavily on accurate diagnosis, proper dosing based on tank volume, and maintaining consistent treatment duration. Metronidazole has become particularly essential for cichlid keepers, discus enthusiasts, and anyone maintaining fish species prone to hexamita infections or hole in the head disease, conditions that can rapidly progress without appropriate intervention.

The primary indication for metronidazole in aquarium fish is the treatment of Hexamita infections and the associated condition known as Hole in the Head Disease or Head and Lateral Line Erosion. Hexamita is a flagellated protozoan parasite that colonizes the intestinal tract and gall bladder of fish, causing severe digestive disturbances, white stringy feces, loss of appetite, and eventual wasting. When left untreated, hexamita infections can progress to the characteristic pitting and erosion of the head and lateral line that gives HITH its name. This condition is particularly common in cichlids, especially discus, oscars, and other large South American species, though it can affect virtually any freshwater fish under conditions of stress and poor water quality.

In freshwater aquarium applications, metronidazole serves as the first-line treatment for hexamita and related diplomonad parasites including Spironucleus species. These organisms cause similar symptoms including lethargy, loss of coloration, refusal to eat, and the production of white, stringy fecal casts that indicate severe intestinal disturbance. The medication is highly effective when treatment begins early, before significant tissue damage has occurred. For cichlid keepers, prophylactic treatment of new arrivals with metronidazole has become standard practice to prevent the introduction of these parasites into established collections. Bloat syndrome in African cichlids, which may have multiple contributing factors including bacterial and protozoal components, often responds favorably to metronidazole therapy.

While metronidazole is primarily a freshwater medication, it does have applications in marine aquarium keeping for treating certain protozoan infections in saltwater fish. Marine velvet and other flagellated parasites may show some susceptibility to metronidazole, though copper-based treatments typically remain the first choice for marine external parasites. The medication's primary marine use involves treating internal flagellates and anaerobic bacterial infections in marine fish that present with symptoms similar to freshwater hexamita infections. Uronema, a ciliated protozoan that can devastate marine fish, is generally not susceptible to metronidazole and requires different treatment approaches.

Beyond its antiprotozoal activity, metronidazole demonstrates significant effectiveness against anaerobic bacteria that can cause internal infections in fish. Conditions involving the swim bladder, intestinal bacterial overgrowth, and certain types of dropsy may respond to metronidazole treatment, particularly when anaerobic bacteria are implicated. The medication's tissue penetration allows it to reach infections in areas that many antibiotics cannot effectively access. Some veterinarians combine metronidazole with other antibiotics to provide broad-spectrum coverage against both anaerobic and aerobic pathogens in severe systemic infections.

When choosing metronidazole over other available medications, aquarists should consider several factors including the specific pathogen involved, the severity of infection, and the species being treated. Metronidazole is the definitive choice when hexamita or other intestinal flagellates are suspected based on symptoms such as white stringy feces, head erosion, or lateral line pitting in susceptible species. The medication is also preferred when anaerobic bacterial involvement is suspected, as many common aquarium antibiotics are ineffective against anaerobic organisms. For mixed infections or uncertain diagnoses, metronidazole combines well with other medications and is frequently paired with antibiotics like kanamycin or praziquantel in commercial preparations.

Dosing metronidazole for aquarium fish requires careful attention to tank volume calculations and the specific formulation being used, as concentrations vary significantly between pharmaceutical-grade powder and commercial preparations. The standard therapeutic dose for tank treatment with pure metronidazole powder is 250 milligrams per 10 gallons of actual water volume, which translates to approximately 6.5 milligrams per liter. When using commercial products like Seachem Metroplex, following the manufacturer's specific instructions is essential as these products are formulated for ease of use with predetermined scoop sizes. Tank volume calculations must account for displacement by substrate, decorations, and equipment to avoid underdosing, which can lead to treatment failure and potential resistance development.

Tank treatment protocol involves first removing any activated carbon from filtration systems, as carbon will rapidly adsorb metronidazole and render treatment ineffective. Calculate the actual water volume in your aquarium, subtracting approximately 10-15% for substrate and decorations in a typical setup. Dissolve the appropriate amount of metronidazole in a small amount of tank water before adding to the aquarium to ensure even distribution. The medication can be added directly to the main tank, though using a hospital tank allows for easier monitoring and prevents medication exposure to invertebrates and plants that may be sensitive. Maintain normal aeration and water circulation during treatment to ensure the medication distributes evenly throughout the water column.

For more targeted treatment and better absorption, metronidazole can be administered through medicated food, which delivers the medication directly to the fish's digestive system where many target organisms reside. The standard food-soaking protocol involves dissolving metronidazole in a small amount of water and mixing it with a binding agent like Seachem Focus or unflavored gelatin to help the medication adhere to food particles. A common recipe calls for 100 milligrams of metronidazole per tablespoon of food, though concentrations can be adjusted based on the severity of infection and the size of fish being treated. Medicated food should be prepared fresh for each feeding as the medication's stability decreases once mixed with food and water.

The standard treatment duration for metronidazole is typically 5-7 days for tank treatment, with the medication redosed every 48 hours following a 25-30% water change. This redosing schedule accounts for the medication's degradation in aquarium water and maintains therapeutic concentrations throughout the treatment period. Some protocols recommend treating for up to 10 days for severe or chronic infections, particularly HITH cases where the disease has progressed significantly. When using medicated food, treatment typically continues for 7-10 days with daily feedings of the medicated preparation, which can be alternated with regular food to maintain appetite and nutrition.

Water changes play a crucial role in metronidazole treatment protocols, serving multiple functions beyond simply diluting accumulated waste products. A 25-30% water change before each redose removes degraded medication and metabolic waste while providing fresh water that helps maintain fish health during treatment stress. The water change should be performed using dechlorinated water matched to the tank's temperature and, if possible, pH and hardness. Gravel vacuuming during treatment water changes helps remove any parasites or bacteria shed by infected fish, reducing the pathogen load in the environment. After the final dose, a larger water change of 40-50% helps clear remaining medication from the system.

Redosing guidelines depend on the treatment method chosen and the specific product being used. For tank treatment with pure metronidazole, redose the full calculated amount every 48 hours following the water change. Commercial products may have different redosing schedules specified on their packaging. If using medicated food as the primary treatment method, no redosing of tank water is necessary unless combining with water treatment for severe infections. Signs that treatment is working include improvement in fecal appearance, return of appetite, increased activity level, and cessation of disease progression. If no improvement is seen after 5-7 days of proper treatment, reassessment of diagnosis and consideration of combination therapy or alternative medications may be warranted.

Metronidazole is generally well-tolerated by most freshwater fish species when used at proper therapeutic doses, but certain side effects and impacts on fish should be monitored during treatment. Some fish may exhibit temporary loss of appetite during the first one to two days of treatment, which typically resolves as they acclimate to the medication's presence in the water. Lethargy and reduced activity are occasionally observed, particularly in fish that are already compromised by infection. Dark coloration or stress patterns may become more pronounced initially, though this often reflects the underlying disease process rather than a direct medication effect. In rare cases, sensitive species may show signs of respiratory distress, increased gill movement, or surface gasping, which warrants immediate water change and discontinuation of treatment.

The impact of metronidazole on biological filtration is considerably less severe than many other aquarium medications, which represents one of its significant advantages for treating established aquariums. Unlike antibiotics that indiscriminately kill both beneficial and harmful bacteria, metronidazole's selective activity against anaerobic organisms means that the primarily aerobic nitrifying bacteria in established filters are largely unaffected at therapeutic doses. However, prolonged treatment or significantly elevated doses can still impact filter bacteria populations, so monitoring ammonia and nitrite levels during extended treatment periods is advisable. If ammonia or nitrite spikes occur, partial water changes and reduced feeding can help manage the situation until the filter colony recovers.

Live aquarium plants generally tolerate metronidazole well at standard therapeutic doses, showing minimal stress or damage during normal treatment protocols. This compatibility makes metronidazole one of the more plant-friendly medications available for treating internal parasites in planted aquariums. However, extended treatment periods beyond the standard 5-7 days may begin to affect more sensitive plant species, particularly fine-leaved varieties and certain stem plants. Some aquarists report temporary growth slowdown or mild leaf damage in heavily planted tanks during treatment, effects that typically reverse once treatment concludes. If maintaining plant health is a priority, using medicated food rather than tank treatment can minimize medication contact with plants.

Invertebrates present a more significant concern when using metronidazole, as snails and certain crustaceans may show adverse reactions to the medication. Ornamental shrimp, particularly the more sensitive varieties like Crystal Red Shrimp and Bee Shrimp, can be negatively affected by metronidazole exposure and should be removed to a separate holding container during treatment. Nerite snails and other popular aquarium snails generally tolerate short-term exposure but may become less active during treatment. Malaysian Trumpet Snails and pond snails are more resilient but should still be monitored. Crayfish and freshwater crabs should be removed from treatment tanks, as their sensitivity to metronidazole is not well documented and losses have been reported.

Water discoloration and other visible changes to tank water are minimal with metronidazole compared to many other aquarium medications. The medication dissolves to produce a slightly cloudy appearance initially that clears within an hour as it fully dissolves and disperses. Unlike methylene blue or malachite green, metronidazole does not stain water, decorations, or silicone significantly. Some users report a slight medicinal odor during treatment, which is normal and not cause for concern. Protein skimmers in marine or brackish setups should be turned off during treatment as they can remove medication from the water. Any foam produced during treatment is typically from normal biological processes rather than medication-related issues and can be skimmed off without concern.

While metronidazole is broadly safe for most freshwater fish species, certain situations and species warrant caution or complete avoidance of this medication. Scaleless fish, including most loach species, certain catfish, and elephant nose fish, can safely receive metronidazole treatment at standard doses, unlike many other medications that are toxic to scaleless species. However, these fish should still be monitored more closely during treatment as their increased permeability may lead to higher tissue concentrations of the medication. Species with documented sensitivity to nitroimidazole compounds should receive reduced doses or alternative treatments when available. Fish that are severely debilitated, not eating for extended periods, or showing signs of organ failure may not tolerate additional medication stress.

Tank conditions that may preclude or complicate metronidazole use include severely compromised biological filtration, recent tank cycling, or ongoing ammonia or nitrite issues. While metronidazole is relatively gentle on filter bacteria, introducing additional stress to an already unstable nitrogen cycle risks compounding problems. Tanks with very low pH (below 6.0) may experience reduced medication efficacy as metronidazole's activity can be pH-dependent. Extremely soft water conditions may also affect drug stability and distribution. If significant water quality issues exist, addressing these before initiating treatment will improve outcomes and reduce the risk of treatment-related complications. Emergency water changes and temporary housing in better-quality water may be necessary for severely ill fish.

Invertebrate and plant sensitivity considerations are important when planning metronidazole treatment in community aquariums. While most plants tolerate the medication well, aquariums housing valuable or sensitive invertebrates require special consideration. Remove ornamental shrimp, especially dwarf shrimp species, before treatment. Snails can often remain in the tank for short treatment periods but should be removed for extended protocols. Live coral in marine applications should never be exposed to metronidazole. Beneficial microfauna populations, including copepods and amphipods that many aquarists cultivate, may be reduced by treatment. When invertebrates cannot be removed, treating affected fish in a separate hospital tank is the preferred approach.

Metronidazole should not be used as a prophylactic treatment without reasonable suspicion of target pathogens, as unnecessary medication exposure can contribute to resistance development and stresses fish without benefit. The medication is specifically indicated for protozoan parasites and anaerobic bacteria; using it for viral infections, most external parasites, or conditions caused by aerobic bacteria will not be effective and wastes valuable treatment time. Avoid using metronidazole simultaneously with certain other medications without understanding potential interactions. Do not treat fish that have recently been exposed to other medications without allowing adequate clearance time between treatments. If fish have not responded to a proper course of metronidazole treatment, repeating the same treatment immediately is unlikely to succeed and suggests either misdiagnosis or the development of resistance.

Understanding drug interactions is essential for safe and effective use of metronidazole in aquarium applications, particularly when combination therapy is needed for complex infections or uncertain diagnoses. Metronidazole should not be combined simultaneously with certain other medications that may create antagonistic effects or increase toxicity. Avoid concurrent use with alcohol-based medications or preparations, as the interaction between metronidazole and alcohol can produce toxic metabolites even in fish. Formalin-based treatments should not be used simultaneously with metronidazole due to potential stress from multiple chemical exposures. When both treatments are needed, complete one course before beginning the other with adequate time between treatments for water changes and fish recovery.

Sequential treatment considerations are important when metronidazole is part of a broader treatment plan. If copper treatment has been used recently, ensure all copper has been removed from the system before introducing metronidazole, as residual copper may increase stress on fish already dealing with medication exposure. The same principle applies in reverse; if metronidazole treatment will be followed by copper treatment for different pathogens, allow 48-72 hours with activated carbon filtration and water changes between treatments. Praziquantel can generally be used safely after metronidazole with minimal washout period, which is convenient since many infections involve both protozoan and helminth parasites. Some commercial products combine these medications specifically because they work well together.

Water conditioner interactions with metronidazole are generally minimal, but certain considerations apply. Most standard dechlorinators, including those that neutralize chloramine, can be used safely with metronidazole. Products containing slime coat enhancers or aloe vera additives are compatible and may even help protect stressed fish during treatment. However, water conditioners that specifically bind heavy metals or medications should be avoided during treatment as they may reduce metronidazole's availability in the water. Prime and similar ammonia-binding conditioners are safe to use and can be helpful if ammonia spikes occur during treatment. Test your water conditioner on a small scale if uncertain about interactions.

Safe and potentially synergistic combinations with metronidazole include several common aquarium medications. Kanamycin sulfate combines well with metronidazole for treating mixed bacterial and protozoan infections, a combination available in commercial products like Seachem KanaPlex used alongside Metroplex. This combination provides coverage against both gram-negative bacteria and the anaerobic organisms and protozoa that metronidazole targets. Praziquantel, the primary treatment for flukes and internal worms, can be used concurrently with metronidazole when both parasites are suspected, as in API General Cure which contains both active ingredients. Erythromycin for gram-positive bacteria is compatible with metronidazole, allowing broad-spectrum coverage when needed. Salt treatment at typical aquarium concentrations does not interfere with metronidazole and can provide additional support for stressed fish.

The most critical precaution when using metronidazole is ensuring complete removal of activated carbon from all filtration systems before treatment begins. Activated carbon is highly effective at adsorbing metronidazole from water, potentially removing the medication within hours and rendering treatment completely ineffective. Check all filter compartments, including those in hang-on-back filters, canister filters, and any carbon-containing filter media or pads. Chemical filtration media designed to remove medications, such as Purigen in its depleted state, should also be removed. Biological media, ceramic rings, and sponge filters can remain in operation. Replace carbon filtration only after treatment is complete and you wish to remove residual medication from the water.

Protecting biological filtration during metronidazole treatment involves several proactive measures, even though this medication is relatively gentle on beneficial bacteria. Reduce feeding during treatment to decrease the ammonia load on the filter system. Monitor ammonia and nitrite levels every one to two days during treatment, especially in tanks with marginal filtration capacity. If parameters begin to rise, small daily water changes of 10-15% can help manage the situation without significantly diluting medication. Having backup biological media seeded in another tank provides insurance against unexpected filter crashes. Consider dosing beneficial bacteria supplements during treatment as additional protection for your nitrogen cycle.

UV sterilizers should be turned off during metronidazole treatment as UV light may degrade the medication and reduce its effectiveness in the water column. The same applies to ozone systems in marine setups. These sterilization methods can be resumed after treatment concludes and will help clear any remaining medication from the system. Protein skimmers in marine or brackish applications should also be disabled as they can physically remove medication from the water through their collection process. Surface skimmers and overflow systems can continue operating normally as they do not significantly affect medication concentration.

Maintaining adequate aeration during metronidazole treatment is important, as sick fish often have compromised gill function and reduced oxygen tolerance, while the medication can create additional metabolic demands. Increase surface agitation through airstone placement or adjusting filter output direction to maximize gas exchange. Fish may position themselves near areas of higher oxygen concentration during treatment; adding additional airstones near rest areas can help. If fish show signs of oxygen stress such as rapid gill movement or surface gasping, immediately increase aeration and consider a partial water change. Temperature should be maintained at the lower end of the species' comfort range during treatment, as warmer water holds less dissolved oxygen.

Human safety considerations when handling metronidazole include wearing gloves during preparation and administration, particularly when working with powder formulations that can become airborne. Avoid direct skin contact with concentrated medication solutions. Wash hands thoroughly after handling medication or treated tank water. Do not eat, drink, or smoke while working with metronidazole. Keep medication containers away from food preparation areas. For disposal, never pour unused medication or treated water into drains, toilets, or natural waterways. Leftover medication should be sealed in its original container and disposed of according to local pharmaceutical waste guidelines. Treated water should undergo carbon filtration before disposal or be allowed to degrade naturally in an isolated container before drain disposal.

Proper storage of metronidazole is essential for maintaining medication potency and ensuring effective treatment when needed. Pure pharmaceutical-grade metronidazole powder should be stored in its original light-resistant container at room temperature, away from direct sunlight and heat sources. Ideal storage temperature ranges from 59-77°F (15-25°C), with protection from moisture being critical for powder formulations. Commercial aquarium preparations like Seachem Metroplex include specific storage instructions that should be followed precisely. Keep all metronidazole products tightly sealed between uses to prevent moisture absorption and degradation. A cool, dark cabinet away from the aquarium's heat and humidity provides ideal storage conditions.

Shelf life considerations vary between pharmaceutical-grade products and commercial aquarium preparations. Pure metronidazole powder, when properly stored, maintains potency for several years and typically carries an expiration date three to five years from manufacture. Commercial aquarium products may have shorter shelf lives depending on their formulation and any additional ingredients. Always check expiration dates before use, as degraded medication may be ineffective or potentially harmful. Once opened, commercial products should be used within the timeframe specified on packaging. Medication that has changed color, developed an unusual odor, or shows signs of moisture contamination should be discarded regardless of expiration date. Medicated food preparations should be made fresh for each treatment course and not stored long-term.

Safe disposal of metronidazole and treated aquarium water requires environmental consideration. Never dispose of aquarium medications by pouring them down drains or flushing them in toilets, as they can affect water treatment systems and aquatic ecosystems. Unused powder or tablets should be mixed with an undesirable substance like coffee grounds or cat litter, placed in a sealed container, and disposed of in regular household trash. Liquid medications can be absorbed onto paper towels or mixed with absorbent material before disposal. Treated aquarium water should ideally be filtered through activated carbon before disposal to remove residual medication. For large volumes of treated water, allowing it to stand in a non-fish container for several days permits natural degradation before disposal. Check with local pharmacies or waste management facilities for medication take-back programs that accept veterinary and aquarium medications.

Freshwater fish species show varying sensitivity to metronidazole, though the medication is broadly tolerated across most commonly kept aquarium fish. Cichlids, the species group most commonly treated with metronidazole due to their susceptibility to hexamita, generally handle the medication well at standard doses. Discus, despite their reputation for sensitivity, typically tolerate metronidazole treatment when water quality is maintained and stress is minimized. Oscars, Flowerhorns, and other large American cichlids commonly receive metronidazole treatment for HITH with good success rates. African cichlids from the Rift Lakes, particularly those affected by bloat syndrome, respond well to metronidazole therapy. Livebearers, tetras, barbs, and most other community fish species can be safely treated at standard concentrations.

Marine fish species considerations differ somewhat from freshwater applications, though metronidazole can be used in saltwater aquariums when indicated. Marine angelfish, tangs, and wrasses that develop internal protozoan infections may benefit from metronidazole treatment, particularly for hexamita-like symptoms. Dosing for marine applications typically mirrors freshwater protocols, though the medication may be less stable in saltwater conditions. Clownfish and other captive-bred marine fish generally tolerate treatment well. Wild-caught marine fish undergoing quarantine may receive prophylactic metronidazole treatment as part of comprehensive parasite prevention protocols. Marine fish that are not eating present challenges for food-based treatment, making tank treatment the primary option despite its limitations.

Scaleless fish and invertebrate warnings require special attention when planning metronidazole treatment in community settings. Unlike many aquarium medications that are toxic to scaleless fish, metronidazole can generally be used safely with loaches, certain catfish species, and other scaleless fish at standard doses. Clown loaches, often kept with cichlids and therefore potentially exposed during treatment, typically tolerate metronidazole without issues. However, monitoring scaleless species more closely during treatment is prudent due to their increased permeability. Freshwater stingrays should be treated with caution, using reduced doses and close observation. All shrimp species should be removed from treatment tanks, with dwarf shrimp being particularly sensitive. Mystery snails and nerites can often remain during short treatments but show reduced activity.

Species-specific dosing adjustments may be warranted in certain situations, though standard dosing is appropriate for most applications. Extremely small fish such as microrasboras and tiny tetras may benefit from starting at 75% of the standard dose with careful observation before proceeding to full strength. Fry and juvenile fish generally tolerate standard doses but should be monitored closely. Very large fish in small hospital tanks may receive higher effective doses due to the medication-to-body-mass ratio; this is usually not problematic but watch for signs of stress. Ancient fish species such as bichirs and lungfish have limited data available regarding metronidazole tolerance, suggesting conservative dosing approaches. When treating valuable or rare specimens, starting with a reduced dose and escalating based on tolerance represents a prudent strategy.

Within the same antiprotozoal category, several alternatives to metronidazole exist for treating hexamita and related protozoan infections. Secnidazole, a closely related nitroimidazole compound, offers similar spectrum activity with potentially improved tissue penetration and longer duration of action, though it is less commonly available in aquarium preparations. Dimetridazole was historically used for similar indications but has become restricted in many regions due to concerns about residues in food animals. Tinidazole represents another nitroimidazole option occasionally encountered in veterinary applications. For aquarists seeking natural or herbal alternatives, some report success with garlic-based treatments, though clinical evidence for effectiveness against hexamita remains limited. Maintaining excellent water quality and providing optimal nutrition remain the most important factors in preventing protozoan infections.

Medications with different mechanisms of action may be preferred in certain situations or combined with metronidazole for broader coverage. Praziquantel addresses a completely different parasite category, targeting flukes and internal worms rather than protozoa, and is commonly combined with metronidazole in commercial preparations for comprehensive parasite treatment. Levamisole offers anthelmintic activity against camallanus worms and other nematodes with some immunostimulant properties. Epsom salt (magnesium sulfate) baths can provide supportive care for fish with intestinal issues alongside specific treatments. For bacterial co-infections that may accompany protozoan disease, kanamycin sulfate provides effective gram-negative coverage that complements metronidazole's anaerobic activity.

Combination treatment options frequently prove more effective than single-medication approaches for complex presentations. The metronidazole and praziquantel combination found in API General Cure addresses both protozoan and helminth parasites simultaneously, useful when the specific pathogen is uncertain or when multiple parasites may be present. Seachem's recommended protocol of Metroplex with KanaPlex provides antiprotozoal and antibacterial coverage for severe internal infections. Focus, Seachem's food-binding product, enables preparation of medicated food containing multiple medications when needed. Triple-sulfa preparations can be used before or after metronidazole treatment when bacterial involvement is suspected. For HITH cases with significant erosion, some aquarists follow metronidazole treatment with vitamin-enhanced foods and improved water quality to support tissue healing. Combining metronidazole with immune-supporting products like garlic-based additives may help fish recover more quickly from infections.